1. Home
  2. VTRS vs DOX Comparison

VTRS vs DOX Comparison

Compare VTRS & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • DOX
  • Stock Information
  • Founded
  • VTRS 1961
  • DOX 1982
  • Country
  • VTRS United States
  • DOX United States
  • Employees
  • VTRS N/A
  • DOX N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • DOX EDP Services
  • Sector
  • VTRS Health Care
  • DOX Technology
  • Exchange
  • VTRS Nasdaq
  • DOX Nasdaq
  • Market Cap
  • VTRS 9.0B
  • DOX 10.2B
  • IPO Year
  • VTRS N/A
  • DOX 1998
  • Fundamental
  • Price
  • VTRS $7.56
  • DOX $83.18
  • Analyst Decision
  • VTRS Hold
  • DOX Strong Buy
  • Analyst Count
  • VTRS 4
  • DOX 5
  • Target Price
  • VTRS $10.50
  • DOX $101.20
  • AVG Volume (30 Days)
  • VTRS 17.3M
  • DOX 894.9K
  • Earning Date
  • VTRS 05-08-2025
  • DOX 05-07-2025
  • Dividend Yield
  • VTRS 6.50%
  • DOX 2.54%
  • EPS Growth
  • VTRS N/A
  • DOX N/A
  • EPS
  • VTRS N/A
  • DOX 4.31
  • Revenue
  • VTRS $14,739,300,000.00
  • DOX $4,869,845,000.00
  • Revenue This Year
  • VTRS N/A
  • DOX N/A
  • Revenue Next Year
  • VTRS $1.20
  • DOX $4.27
  • P/E Ratio
  • VTRS N/A
  • DOX $19.29
  • Revenue Growth
  • VTRS N/A
  • DOX N/A
  • 52 Week Low
  • VTRS $6.85
  • DOX $74.41
  • 52 Week High
  • VTRS $13.55
  • DOX $93.34
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 34.97
  • DOX 41.21
  • Support Level
  • VTRS $7.34
  • DOX $80.92
  • Resistance Level
  • VTRS $7.70
  • DOX $85.72
  • Average True Range (ATR)
  • VTRS 0.43
  • DOX 2.91
  • MACD
  • VTRS 0.01
  • DOX -0.40
  • Stochastic Oscillator
  • VTRS 36.41
  • DOX 34.89

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.

Share on Social Networks: